Stock Markets June 3, 2026 01:38 PM

S&P Upgrades IFF to BBB, Cites Consistent Leverage After Pharma Spin-Off

Rating agency raises short-term score to A-2 and assigns a stable outlook as IFF readies Food Ingredients sale and plans to use proceeds for debt reduction and shareholder returns

By Marcus Reed IFF

S&P Global Ratings raised International Flavors & Fragrances Inc.'s long-term rating to BBB from BBB- and upgraded the short-term rating to A-2 from A-3, citing sustained adjusted debt-to-EBITDA near 3x or below since the divestiture of its Pharma Solutions business. The agency expects the company to use part of an estimated $3.8 billion in net proceeds from its Food Ingredients sale for debt repayment, and projects pro forma annual free operating cash flow of more than $650 million to support dividends in excess of $400 million while keeping leverage near or below 3x over the next two years.

S&P Upgrades IFF to BBB, Cites Consistent Leverage After Pharma Spin-Off
IFF

Key Points

  • S&P upgraded IFF's long-term rating to BBB from BBB- and raised the short-term rating to A-2 from A-3, assigning a stable outlook.
  • IFF expects roughly $3.8 billion in net proceeds from the Food Ingredients sale and plans to use part of the proceeds for debt repayment, aiming for a 2.5x leverage target.
  • S&P projects pro forma annual free operating cash flow above $650 million to support dividends in excess of $400 million while keeping adjusted leverage near or below 3x over the next two years.

S&P Global Ratings raised International Flavors & Fragrances Inc.'s long-term credit rating to 'BBB' from 'BBB-' on Wednesday and boosted the short-term rating to 'A-2' from 'A-3', assigning a stable outlook. The agency pointed to the company's sustained adjusted debt-to-EBITDA ratio at or below roughly 3x since IFF sold its Pharma Solutions segment last year.

IFF has announced the planned divestiture of its Food Ingredients business and anticipates net proceeds of about $3.8 billion. The company intends to use a portion of those proceeds to repay debt, consistent with its stated leverage target of 2.5x. Management also plans to deploy proceeds toward share repurchases and reinvestment in the remaining business.

S&P Global Ratings expects that, on a pro forma basis, IFF will generate more than $650 million of annual free operating cash flow. The agency projects that this cash flow will be sufficient to fund annual dividends totaling more than $400 million while keeping adjusted leverage near or below 3x through the next two years.

On sales growth, S&P projects roughly 1% organic growth for fiscal 2026 after adjusting for last years divestitures. That pace is below IFF's long-term organic growth target range of 3% to 4%. The Food Ingredients sale is expected to close in the second quarter of fiscal 2027. S&P anticipates sales will move closer to the company's 3% to 4% long-term target thereafter as IFF sustains recent volume gains across most of its portfolio and implements targeted price increases intended to offset ongoing input cost inflation.

Regarding profitability, S&P expects IFF's EBITDA margins to hold at about 20% over the next 12 to 18 months. The rating agency notes that margins could expand by at least 150 basis points by 2028 once IFF reduces stranded overhead costs tied to divestitures and fully laps the Food Ingredients sale, provided the company can continue to counter input cost inflation through pricing. S&P added that the remaining three segments have a higher-margin profile that will align IFF more closely with its nearest industry peers.

S&P also outlined scenarios that could affect the rating. The agency could lower IFF's rating if the company sustained adjusted debt-to-EBITDA nearer to 4x as a result of large, debt-financed acquisitions or if management changed its financial policy to target a higher leverage ratio than its stated 2.5x. Conversely, an upgrade is seen as unlikely over the next two years; however, S&P said a future upgrade could be possible over time if IFF sustains leverage comfortably below 3x once it laps its recent divestitures.


Context and implications

The ratings action reflects S&P's assessment of IFF's current leverage metrics and the companys planned use of proceeds from a material divestiture to shore up its balance sheet. The outlook and projections rely on the closing timing for the Food Ingredients divestiture and the company's ability to deliver targeted pricing and volume gains while managing overhead related to divested operations.

Risks

  • IFF's rating could be downgraded if adjusted debt-to-EBITDA moves closer to 4x due to large debt-financed acquisitions or a shift in financial policy - this would impact credit markets and bond investors.
  • Sales growth in fiscal 2026 is projected at about 1% after divestitures, below the company's 3% to 4% long-term target, which could affect investor expectations in the consumer ingredients and specialty chemicals sectors.
  • Margins depend on reducing stranded overhead and successfully offsetting input cost inflation with pricing; failure to achieve these could restrain margin expansion and cash flow available for dividends and buybacks.

More from Stock Markets

Asian markets slip as tech and chip stocks weigh; Nikkei and KOSPI lead declines Jun 4, 2026 ASIC opens formal probe into three KPMG Australia partners amid whistleblower claims Jun 4, 2026 South Korea Labour Chief Urges Tech Giants to Share AI Windfall with Suppliers and Workers Jun 4, 2026 Markets Retreat as AI Momentum Pauses and U.S.-Iran Talks Stall Jun 4, 2026 U.S. Officials Held Early Talks on Taking Equity Stakes in AI Firms, NOTUS Says Jun 4, 2026